Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pfizer Inc (NYSE:PFE)

36.74
Delayed Data
As of Jul 22
 +0.03 / +0.08%
Today’s Change
28.25
Today|||52-Week Range
37.19
+13.82%
Year-to-Date
Pharma Industry Outlook: Fundamentals Remain Strong
Jul 22 / Zacks.com - Paid Partner Content
Pfizer Publishes Final Data from Atopic Dermatitis Studies
Jul 14 / Zacks.com - Paid Partner Content
Biogen Should Either a Buyer or a Seller Be
Jul 22 / TheStreet.com - Paid Partner Content
Biosimilars set topple two of the world's biggest drug franchises
Jul 14 / FT.com - Paid Partner Content
Can You Guess Which Pharma Giant Spends $1 Billion-Plus a Year On Direct-To-Consumer ...
Jul 22 / MotleyFool.com - Paid Partner Content
Pfizer (PFE) Gets FDA Nod for Label Expansion of Prevnar 13
Jul 13 / Zacks.com - Paid Partner Content
Will Pfizer Book Another Healthy Quarter?
Jul 22 / TheStreet.com - Paid Partner Content
Sucampo to Stop Developing Cobiprostone for Oral Mucositis
Jul 12 / Zacks.com - Paid Partner Content
Benzinga's M&A Chatter for Thursday July 21, 2016:
Jul 21 / Benzinga - Paid Partner Content
Shire's (SHPG) Dry Eye Disease Drug Xiidra Gets FDA Nod
Jul 12 / Zacks.com - Paid Partner Content
These 5 Healthcare Stocks Have Huge Dividend Yields -- Are Any Worth Buying?
Jul 21 / MotleyFool.com - Paid Partner Content
Dow Jones ETF: 2 Ways to Buy the Dow
Jul 12 / MotleyFool.com - Paid Partner Content
Technology Earnings Helping Market to Gain
Jul 20 / GuruFocus News - Paid Partner Content
JNJ VS. PFE: Which Is The Better Large Cap Pharma Stock?
Jul 11 / Zacks.com - Paid Partner Content
2 Growth & Income Titans to Buy Today
Jul 20 / StreetAuthority - Paid Partner Content
Pfizer Reports Positive Data on Kidney Cancer Drug Sutent
Jul 11 / Zacks.com - Paid Partner Content
J&J (JNJ) Stock Gains on Q2 Earnings and Improved Outlook
Jul 19 / Zacks.com - Paid Partner Content
Here's How Pfizer's Protecting Its Kidney Cancer Drug From New Competitors
Jul 10 / MotleyFool.com - Paid Partner Content
5 Big Pharma Stocks Struggling to Raise Their Dividends
Jul 19 / MotleyFool.com - Paid Partner Content
Medivation: scarcity value
Jul 06 / FT.com - Paid Partner Content
Roche's Gazyva Fails in Phase III B-cell Lymphoma Study
Jul 18 / Zacks.com - Paid Partner Content
Medivation confident drugs pipeline will win over suitors
Jul 06 / FT.com - Paid Partner Content
Dow 30 Stock Roundup: JPM Q2 Impresses, Orders for Boeing & United Technologies
Jul 18 / Zacks.com - Paid Partner Content
Medivation agrees to $10bn takeover talks
Jul 05 / FT.com - Paid Partner Content
Ultragenyx (RARE) Reports Positive Phase III rhGUS Data
Jul 15 / Zacks.com - Paid Partner Content